サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363075

血液製剤の市場規模、シェア、動向分析レポート：製品タイプ別、抗血栓剤・抗凝固剤タイプ別、用途別、地域別、セグメント別予測、2023年～2030年

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血液製剤の市場規模、シェア、動向分析レポート：製品タイプ別、抗血栓剤・抗凝固剤タイプ別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月18日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液製剤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血液製剤市場規模は2030年までに735億9,000万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 6.4％で拡大すると予測されています。市場を牽引する主な要因としては、血液関連疾患の有病率の増加、いくつかの外科手術における成分の広範な使用、輸血処置数の増加などが挙げられます。

傷害・事故件数の増加、献血の増加、献血に関する意識向上のための政府イニシアチブの高まりは、予測期間中に市場を推進すると予想されます。例えば、2022年11月、米国からの資金援助を受けて、世界保健機関/汎米保健機関（PAHO/WHO）は、ベリーズで命を救うために自発的な献血のための販促品を寄贈する啓発プログラムを実施しました。さらに、血友病や遺伝性血管性浮腫のような多くの慢性および急性の生命を脅かす疾患に対する救命治療薬として、バイオ医薬品および製薬業界における血漿の使用量の増加が、血液製剤市場を押し上げる可能性が高いです。

同市場の主要企業は、提携、M&A、製品上市など数多くの戦略に取り組んでいます。さらに、各社は需要に対応するため、製造施設の拡張に向けた投資の拡大にも注力しています。例えば、2023年5月、PlasmaGen Biosciences社は、インドにおける血漿製品の生産を強化するための新施設の開設を発表しました。この施設は、リーズナブルな価格の製品の需給シナリオを大幅に強化することを目的としています。

しかし、低血圧性輸血反応を含む輸血によるアレルギー反応の発生率の増加が、調査期間中の市場の妨げになると予想されています。さらに、B型肝炎、HIV、ウイルス性出血熱など、輸血中の疾病感染の変化が大きいことも、市場の妨げになる可能性があります。

一方、自動収集システムなどの収集・処理技術の革新は、処理時間を短縮することで製品の品質を向上させることができます。例えば、2022年5月、Vitestro社は革新的な自律型採血装置を発表しました。この装置は、超音波ガイドによる3D再構築と人工知能（AI）を組み合わせたもので、安全かつ正確な採血のためにロボットによる針挿入を行う。このような取り組みにより、予測期間中に有利な機会が創出されると予測されます。

血液製剤市場レポートハイライト

  • 製品別では、大手術や輸血の需要増加により、全血製品セグメントが2022年に最大の市場シェアを占めました。
  • タイプ別では、2022年に抗凝固剤がタイプ別セグメントを支配し、2023年から2030年にかけて有利なCAGRを記録すると予測されます。この成長は、より有効性の高い新製品のイントロダクションと、現在パイプラインにある新製品の商業化の可能性に起因しています。
  • 地域別では、北米はCVD、白血病、血液・神経疾患の罹患率が高いことから、2022年の売上高で市場全体をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品別ビジネス分析

  • 血液製剤市場：製品変動分析
  • 全血
    • 赤血球
    • 顆粒球
    • 血漿
    • 血小板
  • 血液成分
    • 全血成分
    • 濃厚赤血球
    • 赤血球液-LR
    • 凍結血漿
    • 濃縮血小板
    • 寒冷沈殿物
  • 血液誘導体

第5章 抗血栓剤・抗凝固剤タイプ別ビジネス分析

  • 血液製剤市場：抗血栓薬および抗凝固薬のタイプの変動分析
  • 血小板凝集阻害剤
  • 線溶薬
  • 抗凝固剤

第6章 用途別ビジネス分析

  • 血小板増多症
  • 肺塞栓症
  • 腎障害
  • 狭心症血管合併症
  • その他

第7章 地域別ビジネス分析

  • 地域別血液製剤市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米血液製剤市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州血液製剤市場、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域の血液製剤市場、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの血液製剤市場、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • SWOT分析
    • MEA血液製剤市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Strategic Framework
    • Pfizer, Inc
    • Bristol-Myers Squibb Company
    • Leo Pharma A/S
    • Sanofi
    • Xiamen Hisunny Chemical Co., LTD
    • AstraZeneca plc
    • Baxter International Inc
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Blood Preparation Market, by Product, 2018 - 2030 (USD Million)
  • Table 4. Global Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 5. Global Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 6. Global Blood Preparation Market, by Region, 2018 - 2030 (USD Million)
  • Table 7. North America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9. North America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 10. North America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 11. U.S. Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. U.S. Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 13. U.S. Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 14. Canada Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15. Canada Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 16. Canada Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 17. Europe Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
  • Table 18. Europe Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Europe Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 20. Europe Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 21. Germany Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Germany Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 23. Germany Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 24. UK Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 25. UK Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 26. UK Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 27. France Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 29. France Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 30. Italy Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Italy Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 32. Italy Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 33. Spain Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 34. Spain Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 35. Spain Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 36. Sweden Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 37. Sweden Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 38. Sweden Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 39. Denmark Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Denmark Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 41. Denmark Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 42. Norway Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Norway Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 44. Norway Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 49. China Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 50. China Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 51. China Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 52. Japan Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Japan Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 54. Japan Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 55. India Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 56. India Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 57. India Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 58. South Korea Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 59. South Korea Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 60. South Korea Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 61. Australia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 62. Australia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 63. Australia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 64. Thailand Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 65. Thailand Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 66. Thailand Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 67. Latin America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
  • Table 68. Latin America Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 69. Latin America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 70. Latin America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 71. Brazil Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 72. Brazil Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 73. Brazil Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 74. Mexico Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 75. Mexico Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 76. Mexico Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 77. Argentina Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 78. Argentina Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 79. Argentina Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 84. South Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 85. South Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 86. South Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 90. UAE Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. UAE Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 92. UAE Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Blood Preparation Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Preparation, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Blood Preparation Market: Product Movement Analysis
  • Fig. 17 Global Blood Preparation Market, for Whole Blood,2018 - 2030 (USD Million)
  • Fig. 18 Global Blood Preparation Market, for Red Cells,2018 - 2030 (USD Million)
  • Fig. 19 Global Blood Preparation Market, for Granulocytes,2018 - 2030 (USD Million)
  • Fig. 20 Global Blood Preparation Market, for Plasma ,2018 - 2030 (USD Million)
  • Fig. 21 Global Blood Preparation Market, for Platelets,2018 - 2030 (USD Million)
  • Fig. 22 Global Blood Preparation Market, for Blood Components,2018 - 2030 (USD Million)
  • Fig. 23 Global Blood Preparation Market, for Whole Blood Components,2018 - 2030 (USD Million)
  • Fig. 24 Global Blood Preparation Market, for Packed Red Cells,2018 - 2030 (USD Million)
  • Fig. 25 Global Blood Preparation Market, for Leukocyte Reduced Red Blood Cells,2018 - 2030 (USD Million)
  • Fig. 26 Global Blood Preparation Market, for Frozen Plasma,2018 - 2030 (USD Million)
  • Fig. 27 Global Blood Preparation Market, for Platelet Concentrate,2018 - 2030 (USD Million)
  • Fig. 28 Global Blood Preparation Market, for Cryoprecipitate,2018 - 2030 (USD Million)
  • Fig. 29 Global Blood Preparation Market, for Blood Derivatives,2018 - 2030 (USD Million)
  • Fig. 30 Global Blood Preparation Market: Antithrombotic & Anticoagulants Type Movement Analysis
  • Fig. 31 Global Blood Preparation Market, for Platelet Aggregation Inhibitors,2018 - 2030 (USD Million)
  • Fig. 32 Global Blood Preparation Market, for Glycoprotein Inhibitors,2018 - 2030 (USD Million)
  • Fig. 33 Global Blood Preparation Market, for COX Inhibitors,2018 - 2030 (USD Million)
  • Fig. 34 Global Blood Preparation Market, for ADP Antagonists,2018 - 2030 (USD Million)
  • Fig. 35 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
  • Fig. 36 Global Blood Preparation Market, for Fibrinolytics,2018 - 2030 (USD Million)
  • Fig. 37 Global Blood Preparation Market, for Tissue Plasminogen Activator (tPA),2018 - 2030 (USD Million)
  • Fig. 38 Global Blood Preparation Market, for Streptokinase,2018 - 2030 (USD Million)
  • Fig. 39 Global Blood Preparation Market, for Urokinase,2018 - 2030 (USD Million)
  • Fig. 40 Global Blood Preparation Market, for Anticoagulants,2018 - 2030 (USD Million)
  • Fig. 41 Global Blood Preparation Market, for Heparins,2018 - 2030 (USD Million)
  • Fig. 42 Global Blood Preparation Market, for Unfractionated Heparin,2018 - 2030 (USD Million)
  • Fig. 43 Global Blood Preparation Market, for Low Molecular Weight Heparin (LMWH),2018 - 2030 (USD Million)
  • Fig. 44 Global Blood Preparation Market, for Ultra-low Molecular Weight Heparin,2018 - 2030 (USD Million)
  • Fig. 45 Global Blood Preparation Market, for Vitamin K Antagonists,2018 - 2030 (USD Million)
  • Fig. 46 Global Blood Preparation Market, for Direct Thrombin Inhibitors,2018 - 2030 (USD Million)
  • Fig. 47 Global Blood Preparation Market, for Direct Factor Xa Inhibitors,2018 - 2030 (USD Million)
  • Fig. 48 Global Blood Preparation Market, : Application Movement Analysis
  • Fig. 49 Global Blood Preparation Market, for Thrombocytosis,2018 - 2030 (USD Million)
  • Fig. 50 Global Blood Preparation Market, for Pulmonary Embolism,2018 - 2030 (USD Million)
  • Fig. 51 Global Blood Preparation Market, for Renal Impairment,2018 - 2030 (USD Million)
  • Fig. 52 Global Blood Preparation Market, for Angina Blood Vessel Complications,2018 - 2030 (USD Million)
  • Fig. 53 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
  • Fig. 54 Regional Marketplace: Key Takeaways
  • Fig. 55 Regional Outlook, 2022 & 2030
  • Fig. 56 Global Blood Preparation Market, : Region Movement Analysis
  • Fig. 57 North America Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 60 Europe Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 61 Germany Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 62 UK Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 63 France Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 64 Italy Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 65 Spain Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 67 Denmark Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 68 Norway Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 70 Japan Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 71 China Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 72 India Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 74 South Korea Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 78 Mexico Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 80 Middle East and Africa Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 81 South Africa Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Blood Preparation Market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait Blood Preparation Market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-455-0

Blood Preparation Market Growth & Trends:

The global blood preparation market size is expected to reach USD 73.59 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.4% from 2023 to 2030. The key factors driving the market include growing prevalence of blood-related disorders, extensive usage of its components in several surgical procedures, rising number of transfusion procedures.

Rising number of injuries & accidents, increasing blood donations, and growing government initiatives to raise awareness regarding donation are expected to propel the market during the forecast period. For instance, in November 2022, the World Health Organization/ Pan American Health Organization (PAHO/WHO) with funding support from the United States of America conducted an awareness program by donating promotional items for voluntary donation to save lives in Belize . Moreover, the increasing usage of plasma as life-saving therapeutics for numerous chronic and acute life-threatening diseases such as Hemophilia and Hereditary Angioedema in the biopharmaceutical and pharmaceutical industries is likely to boost the blood preparation market.

The operating players in the market are undertaking numerous strategies such as collaborations, mergers & acquisitions, and product launches. Furthermore, the companies are also focusing on extending their investments on expansion of manufacturing facilities with an aim to meet the demand. For instance, in May 2023, PlasmaGen Biosciences announced an opening of its new facility to boost the production of blood plasma products in India . The facility aims to significantly enhance the supply-demand scenario for products at reasonable prices.

However, the growing incidence of allergic reactions through the transfusion including hypotensive transfusion reactions are anticipated to hamper the market in the study period. In addition, high changes of disease transmission during transfusions such as hepatitis B, HIV and viral hemorrhagic fever may impede the market.

On the other hand, innovations in collection and processing technologies such as automated collection systems, can improve the quality of products by reducing the processing time. For instance, in May 2022, Vitestro, introduced an innovative autonomous blood drawing device. The device is combination of ultrasound-guided 3D reconstruction and artificial intelligence (AI) with robotic needle insertion for secure and precise collection . Thus such initiatives are projected to create lucrative opportunities during the forecast period.

Blood Preparation Market Report Highlights:

  • By product, the whole blood product segment held the largest market share in 2022 due to increasing demand for major surgeries and transfusions.
  • By type,anticoagulants dominated the type segment in 2022 and are expected to register a lucrative CAGR from 2023 to 2030. This growth is attributed to the introduction of new products with higher efficacy and the potential commercialization of new products currently in the pipeline.
  • By region, North America led the overall market in terms of revenue in 2022 owing to the high incidence of CVDs, leukemia, and hematological and neurological diseases in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product & Application Snapshot
  • 2.3. Anti-thrombotic & Anticoagulants Type Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Blood Preparation Market: Product Movement Analysis
  • 4.2. Whole Blood
    • 4.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
    • 4.2.2. Red Cells
      • 4.2.2.1. Red Cells Market, 2018 - 2030 (USD Million)
    • 4.2.3. Granulocytes
      • 4.2.3.1. Granulocytes Market, 2018 - 2030 (USD Million)
    • 4.2.4. Plasma
      • 4.2.4.1. Plasma Market, 2018 - 2030 (USD Million)
    • 4.2.5. Platelets
      • 4.2.5.1. Platelets Market, 2018 - 2030 (USD Million)
  • 4.3. Blood Components
    • 4.3.1. Whole Blood Components
      • 4.3.1.1. Whole Blood Components Market, 2018 - 2030 (USD Million)
    • 4.3.2. Packed Red Cells
      • 4.3.2.1. Packed Red Cells Market, 2018 - 2030 (USD Million)
    • 4.3.3. Leukocyte Reduced Red Blood Cells
      • 4.3.3.1. Leukocyte Reduced Red Blood Cells Market, 2018 - 2030 (USD Million)
    • 4.3.4. Frozen Plasma
      • 4.3.4.1. Frozen Plasma Market, 2018 - 2030 (USD Million)
    • 4.3.5. Platelet Concentrate
      • 4.3.5.1. Whole Blood Components Market, 2018 - 2030 (USD Million)
    • 4.3.6. Cryoprecipitate
      • 4.3.6.1. Cryoprecipitate Market, 2018 - 2030 (USD Million)
  • 4.4. Blood Derivatives
    • 4.4.1. Blood Derivatives Market, 2018 - 2030 (USD Million)

Chapter 5. Anti-Thrombotic and Anticoagulants Type Business Analysis

  • 5.1. Blood Preparation Market: Anti-Thrombotic and Anticoagulants Type Movement Analysis
  • 5.2. Platelet Aggregation Inhibitors
    • 5.2.1. Platelets Aggregation Inhibitors Market, 2018 - 2030 (USD Million)
    • 5.2.2. Glycoprotein Inhibitors
      • 5.2.2.1. Glycoprotein Inhibitors Market, 2018 - 2030 (USD Million)
    • 5.2.3. COX Inhibitors
      • 5.2.3.1. COX Inhibitors Market, 2018 - 2030 (USD Million)
    • 5.2.4. ADP Antagonist
      • 5.2.4.1. ADP Antagonist Market, 2018 - 2030 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Others Market, 2018 - 2030 (USD Million)
  • 5.3. Fibrinolytics
    • 5.3.1. Fibrinolytics Market, 2018 - 2030 (USD Million)
    • 5.3.2. Tissue Plasminogen Activator
      • 5.3.2.1. Others Market, 2018 - 2030 (USD Million)
    • 5.3.3. Streptokinase
      • 5.3.3.1. Streptokinase Market, 2018 - 2030 (USD Million)
    • 5.3.4. Urokinase
      • 5.3.4.1. Urokinase Market, 2018 - 2030 (USD Million)
  • 5.4. Anticoagulants
    • 5.4.1. Anticoagulants Market, 2018 - 2030 (USD Million)
    • 5.4.2. Heparins
      • 5.4.2.1. Heparins Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Unfractionated heparin
      • 5.4.2.2.1. Unfractionated heparin Market, 2018 - 2030 (USD Million)
      • 5.4.2.3. Low Molecular Weight heparin
      • 5.4.2.3.1. Low Molecular Weight Heparin Market, 2018 - 2030 (USD Million)
      • 5.4.2.4. Ultra-Low Molecular Weight Heparin
      • 5.4.2.4.1. Ultra-Low Molecular Weight Heparin Market, 2018 - 2030 (USD Million)
    • 5.4.3. Vitamin K Antagonist
      • 5.4.3.1. Vitamin K Antagonist Market, 2018 - 2030 (USD Million)
    • 5.4.4. Direct Thrombin Inhibitors
      • 5.4.4.1. Direct Thrombin Inhibitors Market, 2018 - 2030 (USD Million)
    • 5.4.5. Direct factor Xa inhibitors
      • 5.4.5.1. Direct factor Xa Inhibitors Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Thrombocytosis
    • 6.1.1. Thrombocytosis Market, 2018 - 2030 (USD Million)
  • 6.2. Pulmonary Embolism
    • 6.2.1. Pulmonary Embolism Market, 2018 - 2030 (USD Million)
  • 6.3. Renal Impairment
    • 6.3.1. Renal Impairment Market, 2018 - 2030 (USD Million)
  • 6.4. Angina Blood Vessel Complication
    • 6.4.1. Angina Blood Vessel Complication Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Blood Preparation Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. U.S. Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Canada Blood Preparation Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. UK Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Germany Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. France Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Italy Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Spain Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Denmark Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Sweden Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Norway Blood Preparation Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Japan Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. China Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. India Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Australia Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Thailand Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. South Korea Blood Preparation Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Brazil Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Mexico Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Argentina Blood Preparation Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. South Africa Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Saudi Arabia Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. UAE Blood Preparation Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Kuwait Blood Preparation Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Strategic Framework
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Pfizer, Inc
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Bristol-Myers Squibb Company
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Leo Pharma A/S
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Sanofi
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Xiamen Hisunny Chemical Co., LTD
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. AstraZeneca plc
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Baxter International Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives